Reddy Kavidha, Lee Guinevere Q, Reddy Nicole, Chikowore Tatenda J B, Baisley Kathy, Dong Krista L, Walker Bruce D, Yu Xu G, Lichterfeld Mathias, Ndung'u Thumbi
Africa Health Research Institute, Durban, South Africa.
Weill Cornell Medical College, New York, United States.
Elife. 2025 Feb 20;13:RP96617. doi: 10.7554/eLife.96617.
Persisting HIV reservoir viruses in resting CD4 T cells and other cellular subsets are a barrier to cure efforts. Early antiretroviral therapy (ART) enables post-treatment viral control in some cases, but mechanisms remain unclear. We hypothesised that ART initiated before peak viremia impacts HIV-1 subtype C reservoirs. We studied 35 women at high risk of infection from Durban, South Africa, identified with hyperacute HIV by twice-weekly HIV-RNA testing. Participants included 11 starting ART at a median of 456 (297-1203) days post-onset of viremia (DPOV) and 24 at 1 (1-3) DPOV. Peripheral blood mononuclear cells (PBMCs) were used to measured total HIV-1 DNA by droplet digital PCR (ddPCR) and sequence viral reservoir genomes by full-length proviral sequencing (FLIP-seq). ART during hyperacute infection blunted peak viremia (p<0.0001), but contemporaneous total HIV-1 DNA did not differ (p=0.104). Over 1 year, a decline of total HIV-1 DNA was observed in early treated persons (p=0.0004), but not late treated. Among 697 viral genome sequences, the proviral genetic landscape differed between untreated, late treated, and early treated groups. Intact genomes after 1 year were higher in untreated (31%) versus late treated (14%) and early treated (0%). Treatment in both late and early infection caused more rapid decay of intact (13% and 51% per month) versus defective (2% and 35%) viral genomes. However, intact genomes persisted 1 year post chronic treatment but were undetectable with early ART. Early ART also reduced phylogenetic diversity of intact genomes and limited cytotoxic T lymphocyte immune escape variants in the reservoir. Overall, ART initiated in hyperacute HIV-1 subtype C infection did not impact reservoir seeding but was associated with rapid intact viral genome decay, reduced genetic complexity, and limited immune escape, which may accelerate reservoir clearance in combination with other interventional strategies.
静息 CD4 T 细胞和其他细胞亚群中持续存在的 HIV 储存库病毒是治愈努力的障碍。早期抗逆转录病毒疗法(ART)在某些情况下能够实现治疗后病毒控制,但其机制仍不清楚。我们假设在病毒血症峰值之前开始的 ART 会影响 HIV-1 C 亚型储存库。我们研究了 35 名来自南非德班的高感染风险女性,通过每周两次的 HIV-RNA 检测确定为超急性 HIV 感染。参与者包括 11 名在病毒血症发作后中位数为 456(297 - 1203)天开始接受 ART 的患者,以及 24 名在病毒血症发作后 1(1 - 3)天开始接受 ART 的患者。使用外周血单核细胞(PBMC)通过液滴数字 PCR(ddPCR)测量总 HIV-1 DNA,并通过全长前病毒测序(FLIP-seq)对病毒储存库基因组进行测序。超急性感染期间的 ART 使病毒血症峰值减弱(p<0.0001),但同期总 HIV-1 DNA 无差异(p = 0.104)。在 1 年多的时间里,早期接受治疗的患者中观察到总 HIV-1 DNA 下降(p = 0.0004),而晚期接受治疗的患者则没有。在 697 个病毒基因组序列中,未治疗组、晚期治疗组和早期治疗组的前病毒基因格局有所不同。1 年后完整基因组在未治疗组(31%)高于晚期治疗组(14%)和早期治疗组(0%)。晚期和早期感染时的治疗均导致完整(每月 13%和 51%)与缺陷(2%和 35%)病毒基因组更快地衰减。然而,慢性治疗后 1 年完整基因组仍然存在,但早期 ART 治疗后则检测不到。早期 ART 还降低了完整基因组的系统发育多样性,并限制了储存库中细胞毒性 T 淋巴细胞免疫逃逸变体。总体而言,在超急性 HIV-1 C 亚型感染中开始的 ART 不会影响储存库的播种,但与完整病毒基因组的快速衰减、遗传复杂性降低和免疫逃逸受限有关,这可能与其他干预策略相结合加速储存库的清除。